ABBOTT LABS 4.75 percent 30Nov2036 is a US Corporate Debentures issued by Abbott Laboratories on the 17th of November 2016. The bond matures on the 30th of November 2036 and carries the semi-annual coupon of 4.750%. ABBOTT is trading at 98.10 as of the 25th of February 2025, a 0.66% up since the beginning of the trading day. The bond's open price was 97.46. ABBOTT has about a 40 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Ratings for ABBOTT LABS 475 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of November 2024 and ending today, the 25th of February 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in ABBOTT without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Alpha Finder Now
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ABBOTT financial ratios help investors to determine whether ABBOTT Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABBOTT with respect to the benefits of owning ABBOTT security.